Theromics Inc

Theromics has a new medical device technology to optimize thermal ablation (IGTA) of solid tumors/soft tissue. HeatSYNC™, inexpensively augments thermal ablations of soft tissue by redirecting energy, mitigating “heat sinks” and allowing better targeting of tumors. Our technology will help mitigate the nearly 30% recurrence rate in IGTA by reducing incomplete ablations and making them more effective, less costly and more "patient-centric"